Market Closed -
Euronext Paris
11:35:08 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
25.75
EUR
|
+0.39%
|
|
+8.19%
|
-8.20%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
65.36
|
320
|
417.2
|
383.4
|
472.1
|
432.8
|
-
|
-
|
Enterprise Value (EV)
1 |
53.27
|
296.5
|
332.2
|
327.5
|
328.9
|
439.8
|
533.6
|
581.8
|
P/E ratio
|
-17.6
x
|
-52.1
x
|
107
x
|
-13.9
x
|
-14.3
x
|
-18
x
|
-12.2
x
|
-19.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
45.1
x
|
195
x
|
3,973
x
|
5,477
x
|
19,670
x
|
24.6
x
|
7.05
x
|
3.67
x
|
EV / Revenue
|
36.7
x
|
180
x
|
3,164
x
|
4,679
x
|
13,704
x
|
25
x
|
8.69
x
|
4.93
x
|
EV / EBITDA
|
-12.6
x
|
-46.6
x
|
57.1
x
|
-15.8
x
|
-11.6
x
|
-21.9
x
|
-36.1
x
|
116
x
|
EV / FCF
|
-9.98
x
|
-16.5
x
|
-15.9
x
|
-10.2
x
|
-
|
-3.95
x
|
-5.69
x
|
-
|
FCF Yield
|
-10%
|
-6.05%
|
-6.27%
|
-9.84%
|
-
|
-25.3%
|
-17.6%
|
-
|
Price to Book
|
2.49
x
|
6.51
x
|
2.85
x
|
3.06
x
|
-
|
2.13
x
|
2.43
x
|
2.34
x
|
Nbr of stocks (in thousands)
|
6,895
|
8,080
|
11,161
|
11,205
|
16,830
|
16,808
|
-
|
-
|
Reference price
2 |
9.480
|
39.60
|
37.38
|
34.22
|
28.05
|
25.75
|
25.75
|
25.75
|
Announcement Date
|
3/16/20
|
4/6/21
|
4/1/22
|
4/6/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1.45
|
1.643
|
0.105
|
0.07
|
0.024
|
17.62
|
61.38
|
118
|
EBITDA
1 |
-4.213
|
-6.368
|
5.82
|
-20.67
|
-28.33
|
-20.06
|
-14.8
|
5
|
EBIT
1 |
-4.535
|
-6.821
|
-15.85
|
-26.1
|
-28.88
|
-26.3
|
-25.12
|
-10
|
Operating Margin
|
-312.76%
|
-415.16%
|
-15,093.33%
|
-37,287.14%
|
-120,325%
|
-149.22%
|
-40.93%
|
-8.47%
|
Earnings before Tax (EBT)
1 |
-4.549
|
-7.634
|
4.908
|
-27.74
|
-27.22
|
-28.3
|
-19.8
|
-17
|
Net income
1 |
-3.749
|
-6.146
|
3.78
|
-27.74
|
-27.22
|
-24.2
|
-32.15
|
-22
|
Net margin
|
-258.55%
|
-374.07%
|
3,600%
|
-39,630%
|
-113,433.33%
|
-137.3%
|
-52.38%
|
-18.64%
|
EPS
2 |
-0.5400
|
-0.7600
|
0.3500
|
-2.470
|
-1.960
|
-1.430
|
-2.117
|
-1.330
|
Free Cash Flow
1 |
-5.335
|
-17.94
|
-20.84
|
-32.24
|
-
|
-111.4
|
-93.82
|
-
|
FCF margin
|
-367.93%
|
-1,091.97%
|
-19,847.62%
|
-46,057.14%
|
-
|
-631.87%
|
-152.87%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/16/20
|
4/6/21
|
4/1/22
|
4/6/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
7
|
101
|
149
|
Net Cash position
1 |
12.1
|
23.5
|
85
|
55.9
|
143
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.349
x
|
-6.811
x
|
29.8
x
|
Free Cash Flow
1 |
-5.34
|
-17.9
|
-20.8
|
-32.2
|
-
|
-111
|
-93.8
|
-
|
ROE (net income / shareholders' equity)
|
-17.9%
|
-18.3%
|
-18.2%
|
-20.4%
|
-15.1%
|
-4.9%
|
-19.8%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
3.800
|
6.080
|
13.10
|
11.20
|
-
|
12.10
|
10.60
|
11.00
|
Cash Flow per Share
2 |
-0.4400
|
-0.6400
|
-0.8400
|
-1.950
|
-
|
-3.700
|
-3.190
|
-2.440
|
Capex
1 |
2.3
|
12.8
|
11.8
|
10.4
|
-
|
104
|
72.4
|
-
|
Capex / Sales
|
158.55%
|
777.36%
|
11,234.29%
|
14,885.71%
|
-
|
588.37%
|
117.88%
|
-
|
Announcement Date
|
3/16/20
|
4/6/21
|
4/1/22
|
4/6/23
|
4/11/24
|
-
|
-
|
-
|
Last Close Price
25.75
EUR Average target price
58.5
EUR Spread / Average Target +127.18% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.20% | 469M | | +2.46% | 102B | | -8.98% | 60.79B | | +74.76% | 48.86B | | +13.97% | 37.96B | | +4.56% | 32.37B | | +14.72% | 20.64B | | +11.17% | 16.58B | | +8.81% | 13.93B | | -3.19% | 13.25B |
Other Commodity Chemicals
|